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T-cell receptors bound to peptide–MHC molecules
undergo higher-order oligomerization in solution. This
observation, the low-affinity-recognition properties of T-
cell receptors, and other indications that such receptors
undergo rapid, serial engagement by a single ligand
suggest a dynamic clustering model of T-cell signaling.
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Intracellular signaling initiated by tyrosine kinases is
generally accepted to arise from homotypic or heterotypic
ligand-induced oligomerization of the attached receptor
subunits [1]. These subunit interactions can be promoted
by monomeric ligands with two distinct binding faces
capable of simultaneous association with two receptor
chains, by symmetric or asymmetric dimeric ligands, or by
monomeric ligands forming higher-order structures on a
matrix such as a proteoglycan. In each case, these rela-
tively stable binding events promote transphosphorylation
of key tyrosine residues in the newly associated kinases.
This increases their catalytic activity and also creates
binding sites that recruit substrate proteins, adaptor mole-
cules or other enzymes through Src homology 2 (SH2) or
phosphotyrosine-binding (PTB) domain interactions,
giving rise to a cascade of signaling events within the cell. 
This generic model of transmembrane signaling applies to
antigen-specific activation of T-lymphocytes, which is ini-
tiated by receptor recognition of cell-membrane-associ-
ated ligands composed of antigen-derived peptides bound
to integral membrane proteins encoded by the class I or
class II genes of the major histocompatibility complex
(MHC) [2]. The T-cell receptor is a complex multichain
structure composed of a clone-specific ligand heterodimer
whose α and β chains are encoded by somatically rearrang-
ing gene segments, associated with invariant subunits (γ,
δ, ε and ζ) that each contain one or more tyrosine phos-
phorylation sites within an ‘immunoreceptor tyrosine-
based activation motif’ (ITAM). On T-cell receptor ligand
recognition, the paired tyrosines within the ITAMs are
rapidly phosphorylated by the Src-family kinases Lck
and/or Fyn, and the docking, then activation, of the Syk
family kinase ZAP-70 and other signaling components at
these sites results in second messenger generation by
several distinct pathways [3]. The Lck-associated mole-
cules CD8 and CD4 act as coreceptors in this process [4],
binding to conserved features of the same MHC class I [5]
or class II molecules [6,7], respectively, that are engaged
by the T-cell receptor.
Although this general scheme is well accepted, the molec-
ular basis of ligand-induced kinase activation and sus-
tained signal generation inside T cells is less clear. The
special nature of T-cell receptor recognition places two
important constraints on this system. First, in contrast to
other well characterized ligand–receptor combinations,
these immune receptors represent an extremely diverse
set of individual molecular structures created by somatic
rearrangement of gene segments [8]. These receptor
genes are unlinked to those encoding the protein compo-
nents of their ultimate ligands, the highly polymorphic
MHC class I and class II molecules, and the receptors
themselves are produced in the absence of the peptide
portion of the ligand they eventually recognize. Each of
these diverse receptors must distinguish among thousands
of nearly identical ligands, which differ by a few amino
acid side chains projecting into solvent from the MHC-
bound peptides. There are typically 104–105 identical
MHC class I or class II molecules per antigen-presenting
cell, and the number of specific foreign-peptide-contain-
ing molecules among this cohort leading to T-cell activa-
tion can be as few as 10–100. 
These features of T-cell recognition demand that the
affinity of the T-cell receptor for its specific
peptide–MHC ligand be rather modest, typically in the
10–50 µM range [9–11]. This prevents the mass action
effect of the large pool of irrelevant peptide–MHC mole-
cule complexes on the presenting cell from producing
effective T-cell receptor occupancy that either continu-
ously triggers the T cell or that demands such a high
threshold for activation that a low density of specific
ligand could not be effective. A major consequence of this
low-affinity characteristic of T-cell receptor-ligand inter-
actions is that prolonged occupancy of individual T-cell
receptor cannot be achieved by association of a single T-
cell receptor with its ligand, precluding the continued
generation of intracellular signals by any individually
engaged T-cell receptor over the time course (minutes)
typically required for effective gene activation. 
A second confusing issue in understanding how T-cell
activation occurs is that most available data support the
conclusion that each T-cell receptor complex is
monomeric, with a single αβ ligand-binding unit [12,13].
Likewise, peptide–MHC molecule complexes matching a
specific T-cell receptor binding site are apparently present
primarily or exclusively as monomers on the antigen-pre-
senting cell surface, free to move in the plane of the mem-
brane. Thus, although multiple ligand–receptor
interactions may take place when lymphocytes and
antigen-presenting cells meet, these interactions are
monomeric in nature at molecular distances. Yet many
published results argue that T-cell receptor crosslinking
is, as in other receptor-associated kinase systems, required
for signaling to take place [14]. When combined with the
previous problem of low affinity, one is left perplexed at
how the initially monomeric and rapidly dissociating T-
cell receptor–ligand pairs are transformed into these pre-
sumably required oligomeric structures.
Part of the answer to this problem lies with the CD4 and
CD8 coreceptors. Although the direct biochemical evi-
dence is meager, it is generally accepted that these mole-
cules interact with the same peptide–MHC molecule
ligand that is bound to the T-cell receptor, stabilizing the
otherwise rapidly dissociating complex [15], and con-
tributing a key kinase, Lck [16], which helps drive the sig-
naling cascade [4]. Direct formation of T-cell
receptor–CD4 heterodimers mediated by chimeric anti-
bodies leads to intracellular T-cell receptor-associated
phosphorylation events indistinguishable from those seen
with antigen-bearing presenting cells [17], arguing that
this heterodimerization event is central to effective signal-
ing under physiologic conditions. Nevertheless, the best
current estimates are that, even with coreceptor function,
ligand dissociates from T-cell receptor within
1–2 minutes, providing little time for sustained signal gen-
eration compared to long-lived complexes between
growth factors and their receptors. 
This kinetic problem is accentuated by the recent report of
serial T-cell receptor engagement [18]. By examining
endocytic removal of T-cell receptors from the lymphocyte
surface in the presence of different concentrations of
peptide–MHC class II ligand, a single peptide–MHC class
II ligand has been found to engage and sequentially trigger
up to 200 T-cell receptor molecules in less than an hour!
This apparent ability of an MHC ligand to jump from one
T-cell receptor to another at a high rate also argues against
formation of a stable oligomeric structure capable of pro-
longed signaling over a time scale greater than a few
minutes, whereas biochemical analysis shows sustained
second messenger generation for at least 30–60 minutes
when a T-cell interacts with an antigen-presenting cell. 
Two new reports, one providing evidence for ligand-
dependent assembly of high-order T-cell receptor
oligomers [19] and a second on the dimerization potential
of the CD4 coreceptor [20], add a new dimension to our
understanding the details of the molecular events
involved in T-cell receptor signal generation, and provide
clues to how these kinetic problems in antigen-dependent
T-cell activation can be overcome. 
Using a method called quasi-elastic light scattering, Reich et
al. [19] have studied the behavior of soluble forms of
peptide–MHC class II molecule complexes and of their
cognate αβ T-cell receptors either alone or after mixing.
With this method, it is possible to estimate the shape of a
complex and the number of subunits it contains. In solu-
tion, complexes of an antigenic cytochrome peptide bound
to the mouse I-Ek MHC class II molecule behave as
monomers, even at very high protein concentrations.
Soluble T-cell αβ receptors also behave as monomers under
similar conditions. A very different result is obtained,
however, upon mixing the ligand and receptor solutions. At
low concentrations of the two components, they behave as
independent subunits. As the concentration approaches the
known KD of the interactions of this T-cell receptor–ligand
pair, the light scatter changes, consistent with the formation
of peptide–MHC-engaged T-cell receptor complexes. 
The novel finding is that increasing the concentration of
the reactants beyond this point leads to even higher-order
assemblies, first with two ligand–receptor complexes per
oligomer, and then with perhaps six ligand–receptor pairs
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each. Thus, T-cell receptor interaction with ligand seems
to lead previously non-associated proteins to bind together
into moderately stable structures with increasing numbers
of subunits. The most obvious implication of these in vitro
results is that recognition events between monomeric
reactants free to move in the plane of the membrane —
peptide–MHC molecule and T-cell receptor — may lead
to the formation of quasi-stable clusters of engaged T-cell
receptor on the lymphocyte surface. 
The biological relevance of these in vitro associations needs
to be tested, and the underlying mechanism is as yet
unknown. Ligand binding may induce a conformational
change in the T-cell receptor and/or MHC molecule, creat-
ing a new structure with novel sites for self-association.
Claims that the T-cell receptor undergoes conformational
change as a prelude to effective signaling have been made
based on indirect functional data [21], but no biochemical
or biophysical data support this contention at present. 
An alternative explanation is one I offered four years ago
in these pages [22]. The crystal structure of MHC class II
molecules showed a ‘dimer of dimers’ organization [23].
Although such dimers are not typically seen by conven-
tional biochemical approaches or with the purified soluble
class II molecules used by Reich et al. [19], one could
imagine an intrinsic low affinity of association for these
molecules that is not apparent at the tested protein con-
centrations. Similar weak self-association may also be a
characteristic of T-cell receptors. In the plane of the cell
membrane, only transient self-association would therefore
occur; but upon accumulation of monomeric ligand–T-cell
receptor pairs in the cell–cell contact zone during antigen
presentation to T cells, or in the concentrated solutions
used by Reich et al. [19], these weak lateral associations
are now joined by the added ‘vertical’ affinity of T-cell
receptor–ligand recognition (Figure 1). This forms a struc-
ture with four regions of contact rather than just one zone
of interaction. Binding through multiple low-affinity sites
is known to generate high avidity complexes — this
results from preferential rebinding facilitated by the
remaining tether site(s) between the two molecules when
one site of association is lost.
This view is also consistent with a second recent observa-
tion. Wu et al. [20] have reported the structure of a soluble,
four domain form of CD4. The new structure shows a sym-
metric dimer with the two CD4 ectodomains arranged in a
V-like array through interactions of the membrane-proxi-
mal D4 domain. In solution, this dimer forms only to a very
small extent, again implying a very weak intrinsic self-asso-
ciation constant. This dimeric state may be promoted
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Dynamic clustering model for sustained T-cell receptor signaling. 
(a) Receptor–ligand–coreceptor complexes enter into clusters in the
cell–cell contact zone (as in Figure 1). Cluster growth concentrates
both the cognate ligand, so rebinding is favored over diffusion away
from the site, and the second messengers that inhibit negative
regulators of T-cell receptor signaling. (b) Surface view of clustered 
T-cell receptors and CD4 coreceptors. Clustering may physically limit
access of negative regulators to receptor molecules. (c) As full
signaling is achieved, the receptors would be endocytosed, leaving
free ligand to recruit new T-cell receptors to the cluster and sustain
signaling. Eventually the pool of recruitable receptor molecules would
diminish; the protective signals would decrease in local concentration,
allowing negative regulators to shut down signaling.
under more physiological conditions by intracellular
binding events that are not present in this soluble model
system and that may be modulated by tyrosine phosphory-
lation by CD4-associated Lck. Furthermore, other work
has shown that MHC class II molecules have two distinct,
spatially separated sites controlling association with CD4
[24], implying that a class II molecule interacts either with
multiple sites on CD4 or with multiple CD4 molecules.
The observation of higher-order structures in the light-
scattering studies is remarkably evocative of the
‘immunon’ model of lymphocyte activation, originally pro-
posed by Dintzis and coworkers nearly two decades ago
[25]. These investigators used model ligand oligomers of
varying valency and epitope density to investigate the
structural basis of T- and B-cell activation. They found
that activation through B-cell or T-cell receptors requires
a minimal structure consisting of 8–10 physically linked
epitopic sites spaced at ~100 Å, and concluded that an
oligomer of a similar number of receptors is needed for
effective intracellular signaling [26]. The tendency for
hexameric complexes to form in solutions containing T-
cell receptors and MHC ligand may be a physical reflec-
tion of the basic organization of such a signaling oligomer.
This subunit number also agrees with the CD4 multimer
structure calculated to be necessary to explain the quanti-
tative effects of mixing wild-type CD4 with a dominant-
negative mutant CD4 on cell surfaces [27]. 
From these new findings, one is tempted to ascribe to
receptor/coreceptor oligomerization a key role in initiating
the phosphorylation events that underlie all T-cell recep-
tor signal transduction. However, the data on signaling by
T-cell receptor–CD4 dimers, and the evidence for rapid
ligand shuttling between multiple T-cell receptor mole-
cules, raise serious questions about the necessity for
oligomerization for initiating phosphorylation and the
existence of any such structures with a lifetime of more
than a minute or so. Do these observations raise concerns
about the physiological relevance of the new data
obtained with purified proteins? Not at all. It is quite pos-
sible to construct a scenario that combines all these recent
observations into a coherent whole that provides a satisfy-
ing explanation for how the peculiar recognition proper-
ties of the T-cell receptor can be used to generate
sustained intracellular signaling.
The initial T-cell receptor–ligand interactions would be
monomeric. The first oligomerization event contributing to
effective signaling may typically involve this monomeric
complex and CD4 or CD8 — a hetero-oligomerization
event that recruits an additional tyrosine kinase molecule
(Lck) to the engaged receptor, and that has been shown to
be important for generating optimal early tyrosine phos-
phorylation signals [17]. The co-association of two engaged
T-cell receptor molecules, in contrast, gives a weak signal
of a distinct quality from that seen with strong
peptide–MHC molecule ligands, indicating that pure T-
cell receptor oligomerization in the absence of coreceptor
association is a less effective mode of signal generation.
Such signaling could nevertheless account for the initia-
tion of kinase activation in cells under conditions in which
coreceptor recruitment is limited or not possible, and
would be in accord with the results Reich et al. [19]
obtained in the absence of coreceptor. 
As ligand-engaged receptor–coreceptor or receptor–recep-
tor oligomers accumulate in the adhesion patch between
the T-cell and presenting cell, they can rapidly form
higher-order structures, with an additional contribution
from the dimerization tendency of the associated CD4
proteins in the former case. This clustering could con-
tribute to effective signaling in several distinct ways
(Figure 2). First, because clustering requires specific
recognition, a high local concentration will be generated of
receptor molecules and their matched ligands, as pointed
out by Reich et al. [19]. This concentrating effect will
enhance the likelihood that ligand rebinding to a receptor
after dissociation will be favored over diffusion away from
the cell-interaction zone [28]. If the rebinding rate is
greater than the dissociation rate, then low-affinity recog-
nition events can produce sustained signaling.
Second, the creation of a localized cloud of signaling
oligomers would concentrate second messenger molecules
and adaptor proteins in a small region of the cell. This con-
centrating effect may be of critical importance in allowing
positive signals to be produced in the face of negative regu-
lators of T-cell receptor function; indeed, our own recent
data argue that it is essential to accumulate such positive
signals rapidly, as they are required to oppose the interfer-
ing effect of phosphatases (unpublished data). 
Lastly, the physical organization of the cluster may itself
help protect the more central receptor molecules from
attack by membrane-bound phosphatases, such as CD45,
and may also facilitate binding to adaptor and signaling mol-
ecules while providing an unsatisfactory architecture for
interaction with inhibitory proteins. T-cell receptor endocy-
tosis is correlated with formation of fully effective signaling
complexes (our unpublished data), so on ligand–receptor
dissociation within the cluster, those receptors that have
already contributed to signaling can be internalized (Figure
2). This would free previously engaged peptide–MHC
ligands to occupy new T-cell receptors, which would
thereby be recruited to the cluster. Thus, both the ligand-
induced clustering predicted by Reich et al. [19] and the
rapid cycling of MHC ligands from one T-cell receptor to
another can be incorporated into a single model.
The new observations may therefore argue that T-cell
receptor signalling is an extremely dynamic process. This
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process must eventually be shut down; presumably, as the
pool of available T-cell receptor molecules declines, the
inability to sustain the signaling clusters by recruiting new
receptor molecules would lead to a reduction in the rate of
signaling [29]. This would in turn diminish the ability of
downstream effector molecules to interfere with the action
of signaling inhibitors, accelerating the rate of decline in
second messenger generation and eventually extinguish-
ing signal transduction. The specific steps and timing of
this postulated lively molecular dance will be for the
future to reveal.
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